Out of hospital treatment of acute pulmonary embolism in patients with a low NT‐proBNP level

Büller, 2004, Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 401S, 10.1378/chest.126.3_suppl.401S Koopman, 1996, Treatment of deep venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low‐molecular‐weight heparin administered at home. The Tasman study group, N Engl J Med, 334, 682, 10.1056/NEJM199603143341102 Aujesky, 2005, Cost‐effectiveness of low‐molecular‐weight heparin for treatment of pulmonary embolism, Chest, 128, 1601, 10.1378/chest.128.3.1601 Levine, 1996, A comparison of low‐molecular‐weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep‐vein thrombosis, N Engl J Med, 334, 677, 10.1056/NEJM199603143341101 Wells, 1998, Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low molecular‐weight heparin. A comparison of patient self‐injection with homecare injection, Arch Intern Med, 1158, 1809, 10.1001/archinte.158.16.1809 Harrison, 1998, Assessment of outpatient treatment of deep vein thrombosis with low molecular heparin, Arch Intern Med, 158, 2001, 10.1001/archinte.158.18.2001 Douketis, 2001, Prognosis in pulmonary embolism, Curr Opin Pulm Med, 7, 354, 10.1097/00063198-200109000-00018 Aujesky, 2006, A prediction rule to identify low‐risk patients with pulmonary embolism, Arch Intern Med, 166, 169, 10.1001/archinte.166.2.169 Hall, 2004, Essential biochemistry and physiology of NT‐proBNP, Eur J Heart Fail, 6, 257, 10.1016/j.ejheart.2003.12.015 Klok, 2008, Brain‐type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism, Am J Resp Crit Care Med, 178, 425, 10.1164/rccm.200803-459OC Coutance, 2008, Prognostic value of brain natriuretic peptide in acute pulmonary embolism, Crit Care, 14, R109, 10.1186/cc6996 Ten Wolde, 2003, Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism, Circulation, 107, 2082, 10.1161/01.CIR.0000070020.79932.DB Kucher, 2003, Prognostic role of brain natriuretic peptide in acute pulmonary embolism, Circulation, 107, 2545, 10.1161/01.CIR.0000074039.45523.BE Logeart, 2007, Biomarker‐based strategy for screening right ventricular dysfunction in patients with non‐massive pulmonary embolism, Intensive Care Med, 33, 286, 10.1007/s00134-006-0482-1 Kucher, 2003, Low pro‐brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism, Circulation, 107, 1576, 10.1161/01.CIR.0000064898.51892.09 Pruszczyk, 2003, N‐terminal pro‐brain natriuretic peptide in patients with acute pulmonary embolism, Eur Respir J, 22, 649, 10.1183/09031936.03.00023303 Binder, 2005, N‐terminal Pro‐Brain Natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism, Circulation, 112, 1573, 10.1161/CIRCULATIONAHA.105.552216 Kostrubiec, 2005, Biomarker‐based risk assessment model in acute pulmonary embolism, Eur Heart J, 26, 2166, 10.1093/eurheartj/ehi336 Vuilleumier, 2009, Cardiac biomarkers for risk stratification in non massive pulmonary embolism: a multicenter prospective study, J Thromb Haemost, 7, 391, 10.1111/j.1538-7836.2008.03260.x Lega, 2009, Natriuretic peptides and troponins in pulmonary embolism: a meta‐analysis, Thorax, 64, 869, 10.1136/thx.2008.110965 1997, The Columbus Investigators. Low‐molecular‐weight heparin in the treatment of patients with venous thromboembolism, N Engl J Med, 337, 657, 10.1056/NEJM199709043371001 Simonneau, 1997, A comparison of low‐molecular‐weight heparin with unfractionated heparin for acute pulmonary embolism, N Engl J Med, 337, 663, 10.1056/NEJM199709043371002 Caprini, 2005, Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs, J Vasc Surg, 42, 726, 10.1016/j.jvs.2005.05.053 Panis, 2004, Identifying inappropriate hospital stay in patients with venous thromboembolism, Eur J Intern Med, 15, 39, 10.1016/j.ejim.2003.12.001 Van Der Meer, 2005, Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3‐month follow‐up in patients with acute pulmonary embolism, Radiology, 235, 798, 10.1148/radiol.2353040593 Schulman, 2005, Definition of major bleeding in clinical investigations of antihemostatic medicinal products in nonsurgical patients, J Thromb Haemost, 3, 692, 10.1111/j.1538-7836.2005.01204.x PSQ18: http://www.rand.org/health/surveys_tools/psq/index.html. Meignan, 2000, Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis, Arch Intern Med, 160, 159, 10.1001/archinte.160.2.159 Agterof, 2009, Risk stratification of patients with pulmonary embolism based on pulse rate and D‐dimer concentration, Thromb Haemost, 4, 683 Kovacs, 2000, Outpatient treatment of pulmonary embolism with dalteparin, Thromb Haemost, 83, 209, 10.1055/s-0037-1613787 Beer, 2003, Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients, Thromb Haemost, 1, 186, 10.1046/j.1538-7836.2003.00005.x Siragusa, 2005, Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients, Ann Oncol, 4, 136, 10.1093/annonc/mdi923 Wells, 2005, A randomized trial comparing 2 low‐molecular‐weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism, Arch Intern Med, 165, 733, 10.1001/archinte.165.7.733 Olsson, 2006, Outpatient tinzaparin therapy in pulmonary embolism quantified with ventilation‐perfusion scintigraphy, Med Sci Monit, 12, I Davies, 2007, Early discharge of patients with pulmonary embolism: a two‐phase observational study, Eur Respir J, 30, 708, 10.1183/09031936.00140506 Goldhaber, 2001, Thrombolysis in pulmonary embolism: a debatable indication, Thromb Haemost, 86, 444, 10.1055/s-0037-1616242 Bova, 2009, Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism; a prospective, multicentre, cohort study with three months of follow‐up, J Thromb Haemost, 7, 938, 10.1111/j.1538-7836.2009.03345.x Hama, 1995, Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction, Circulation, 92, 1558, 10.1161/01.CIR.92.6.1558